Wave Life Sciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2013 | $-3.6M | $-3.6M | $47.0K | — |
| FY2014 | $-4.4M | $-5.0M | $590.0K | — |
| FY2015 | $-12.5M | $-14.4M | $1.9M | $4.0M |
| FY2016 | $-31.9M | $-37.5M | $5.6M | — |
| FY2017 | $-83.7M | $-102.6M | $18.9M | — |
| FY2018 | $-22.9M | $-32.8M | $9.9M | — |
| FY2019 | $-188.2M | $-192.1M | $3.9M | — |
| FY2020 | $-116.0M | $-117.3M | $1.3M | — |
| FY2021 | $-89.0M | $-89.6M | $560.0K | — |
| FY2022 | $-127.8M | $-129.1M | $1.4M | — |
| FY2023 | $-19.4M | $-20.5M | $1.1M | — |
| FY2024 | $-151.0M | $-152.0M | $938.0K | — |
| FY2025 | $-187.5M | $-188.2M | $718.0K | — |